Streetbeat News

Products Services

JSPR

Jasper Therapeutics, Inc. (NASDAQ:JSPR) announced the pricing of its underwritten offering of 3.9 million shares at $12.95 per share, aiming to raise approximately $50 million. The proceeds are intended for the advancement of its clinical and preclinical development programs, including briquilimab for mast-cell driven diseases, and for general corporate purposes. The offering, supported by both new and existing investors, is expected to close on February 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:01 pm

COTY

Coty Inc. (NYSE:COTY) has entered into a long-term agreement with Italian luxury fashion brand Marni to develop, produce, and distribute a line of fragrances and beauty products beyond 2040, aiming to strengthen its presence in the luxury fragrance segment, particularly in Asia and Europe. This partnership aligns with Coty's strategic direction of focusing on fashion-driven licenses with multi-category potential. The first product launch is expected in 2026. Additionally, Coty renewed its license agreement with bruno banani for over twenty years, targeting younger consumers and the scented care market.

Portfolio Pulse from Nabaparna Bhattacharya

February 06, 2024 | 2:01 pm

AMIX

Autonomix Medical has been granted authorization by an ethics committee for a proof-of-concept human clinical study to evaluate its proprietary ablation technology for treating pancreatic cancer pain. This marks the first study to assess radiofrequency (RF) ablation through a transvascular approach aimed at reducing pain linked to pancreatic cancer. The company is on schedule to begin enrollment for the study in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:52 pm

COHR

PLTR

TENX

Shares of Palantir Technologies, Tenax Therapeutics, and Coherent surged after positive financial results and patent approval news. Palantir reported better-than-expected Q4 sales and provided positive guidance. Tenax Therapeutics' shares soared following the USPTO's allowance of its patent for treating pulmonary hypertension. Coherent's shares increased after reporting strong Q2 results and improving its Q3 outlook.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:51 pm

INCY

MOR

NVS

Novartis AG (NVS) has announced a voluntary public takeover offer to acquire MorphoSys AG (MOR) for €2.7 billion, aiming to enhance its oncology pipeline and global hematology footprint. The deal includes investigational treatments pelabresib and tulmimetostat. Separately, MorphoSys agreed to sell all rights related to tafasitamab to Incyte Corporation (INCY) for $25 million, transferring full development and commercialization responsibilities to Incyte.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 1:46 pm

LAES

SEALSQ Corp (NASDAQ:LAES) announced plans to establish an Open Semiconductors Assembly and Test Center in the US, focusing on semiconductor technology, post-quantum cryptography, and AI. The initiative aims to enhance supply chain resilience and security, supported by the CHIPS Act in the US and the EU Chips Act. The US-based center will integrate quantum-resistant cryptographic capabilities into semiconductor architectures, offering protection against quantum computing threats.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:45 pm

PLUG

Plug Power, Inc (NASDAQ:PLUG) shares dropped over 3% in premarket trading after announcing the restart of its hydrogen plant in Charleston, Tennessee, which adds about ten tons per day of liquid hydrogen supply to the U.S. market. This increases Plug's total production capacity to approximately 25 tons per day. The company also highlighted design improvements for better plant efficiency and plans to transport liquid hydrogen to customers across North America, focusing on high-demand areas. Additionally, Plug has started production of liquid green hydrogen at its Georgia plant, the largest in the U.S., and signed a contract for a 500 MW electrolyzer project in Europe.

Portfolio Pulse from Nabaparna Bhattacharya

February 06, 2024 | 1:43 pm

BSGM

BioSig Technologies, Inc. announced that its PURE EP System has been used in over 100 patient cases, marking a significant milestone for the company's innovative technology designed to improve the outcomes of electrophysiology procedures.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:42 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) reported a 123.0% increase in Bitcoin mined in January 2024 compared to the same period last year, totaling 330 Bitcoins. Despite this growth, there was a month-over-month production decline due to lower transaction fees and higher electricity costs at the Gedu datacenter. The company is expanding its infrastructure with new datacenters in Ohio and Norway and advancing in AI cloud services. It also announced leadership changes, with Jihan Wu becoming CEO in March 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:41 pm

CLH

Clean Harbors, Inc. (NYSE:CLH) has announced its agreement to acquire HEPACO for $400 million in cash, aiming to enhance its Environmental Services segment. The acquisition, expected to close in the first half of 2024, is projected to generate $20 million in cost synergies and efficiency gains. HEPACO's addition will expand Clean Harbors' emergency response capabilities and geographic footprint. The transaction is aligned with Clean Harbors' long-term strategic plan, Vision 2027, and is expected to offer significant growth opportunities, including complementary product offerings and meaningful cross-selling opportunities.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:40 pm